EUCTR2008-005955-40-GB进行中（未招募）1 期
Induction of Heme Oxygenase-1: a therapeutic approach to reduce hepatic ischaemia-reperfusion injury in liver surgery - HOLS study
niversity of Edinburgh0 个研究点目标入组 42 人开始时间: 2009年4月16日最近更新:
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 42
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Patients undergoing hepatectomy with resection of three or more hepatic segments at the Royal infirmary of Edinburgh will be eligible for inclusion in the study. These patients will demonstrate detectable hepatic injury post-operatively.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Patients undergoing minor resections will be excluded. Jaundiced (bilirubin >100 µmol l-1) patients and those with established cirrhosis will also be excluded. Patients who have had a previous liver resection will be excluded. Patients who are unable to give informed consent will be excluded. Patients who are pregnant or breast feeding will also be excluded.
研究者
相似试验
已完成
不适用
Heme Oxygenase-1 in Liver Surgeryiver surgery/pharmacological preconditioningSurgeryLiver surgeryISRCTN94278797niversity of Edinburgh (UK)42
进行中（未招募）
1 期
In vivo induction of heme oxygenase-1 (HO-1) in the metabolic syndrome (MetS).Influence of heme arginate (Normosang) infusion on heme oxygenase-1 activity, endothelial dysfunction, insulin resistance and adipose tissue inflammation related to the metabolic syndrome - In vivo induction of HO in MetS.Subjects suffer from the metabolic syndrome. Effects of study medication on insulin resistance and vascular function will be studied respectively.MedDRA version: 12.1Level: LLTClassification code 10022489Term: Insulin resistanceMedDRA version: 12.1Level: LLTClassification code 10052066Term: Metabolic syndromeMedDRA version: 12.1Level: LLTClassification code 10048554Term: Endothelial dysfunctionEUCTR2010-020875-22-NLRUNMC16
已完成
2 期
In vivo induction of heme oxygenase-1 (HO-1) in the metabolic syndrome (MetS). Influence of heme arginate (Normosang) infusion on heme oxygenase-1 activity, endothelial dysfunction, insulin resistance and adipose tissue inflammation related to the metabolic syndromeatherosclerosis in the metabolic syndrome1001842410003216NL-OMON34409niversitair Medisch Centrum Sint Radboud16
招募中
不适用
The effects of heme arginate treatment on insulin resistance and vascular dysfunction related to obesity.Metabolic syndrome, insulin resistance and endothelial dysfunction.NL-OMON29539Radboud University Nijmegen Medical Centre16
已完成
1 期
Effects of Heme Arginate in Healthy Male SubjectsHealthy SubjectsHeme OxygenaseGenetic PolymorphismNCT00682370Daniel Doberer15